[HTML][HTML] Life cell imaging of amiodarone sequestration into lamellar bodies of alveolar type II cells

T Haller, A Jesacher, A Hidalgo, C Schmidt - Toxicology in Vitro, 2024 - Elsevier
Amiodarone is widely used to treat cardiac arrhythmias and is very effective in preventing
these disorders. However, its use is limited by a wide range of adverse effects, mainly …

Altered surfactant homeostasis and alveolar epithelial cell stress in amiodarone-induced lung fibrosis

P Mahavadi, I Henneke, C Ruppert… - Toxicological …, 2014 - academic.oup.com
Amiodarone (AD) is a highly efficient antiarrhythmic drug with potentially serious side effects.
Severe pulmonary toxicity is reported in patients receiving AD even at low doses and may …

Regulation of macroautophagy in amiodarone‐induced pulmonary fibrosis

P Mahavadi, L Knudsen, S Venkatesan… - The Journal of …, 2015 - Wiley Online Library
Amiodarone (AD) is an iodinated benzofuran derivative, especially known for its
antiarrhythmic properties. It exerts serious side‐effects even in patients receiving low doses …

Effects of metabolites and analogs of amiodarone on alveolar macrophages: structure-activity relationship

D Quaglino, HR Ha, E Duner… - … of Physiology-Lung …, 2004 - journals.physiology.org
Amiodarone, an antiarrhythmic drug toxic toward the lung, is metabolized through sequential
modifications of the diethylaminoethoxy group to mono-N-desethylamiodarone (MDEA), di-N …

Quantitative X-ray microanalysis of alveolar macrophages after long-term treatment with amiodarone

RG Kirk, P Lee, MJ Reasor - Experimental and molecular pathology, 1990 - Elsevier
Abstract Treatment with the iodine-containing antiarrhythmic drug, amiodarone, can cause
pulmonary toxicity. Alveolar macrophages are particularly susceptible to formation of lipid …

Intratracheal amiodarone administration to F344 rats directly damages lung airway and parenchymal cells

MD Taylor, JM Antonini, JR Roberts, SS Leonard… - Toxicology and applied …, 2003 - Elsevier
Amiodarone (AD) is gaining support as a first-line antiarrhythmic drug despite its potentially
fatal pulmonary toxicity involving inflammation and fibrosis. We previously reported a model …

Intracellular sequestration of amiodarone: role of vacuolar ATPase and macroautophagic transition of the resulting vacuolar cytopathology

G Morissette, A Ammoury, D Rusu… - British journal of …, 2009 - Wiley Online Library
Background and purpose: Tissue deposits of the anti‐arrhythmic drug amiodarone are a
major source of side effects (skin discoloration, etc.). We addressed the mechanism of the …

[PDF][PDF] Amiodarone attenuates apoptosis, but induces phospholipidosis in rat alveolar epithelial cells

E Kapatou, A Skyrlas, MG Agelaki, C Pantos… - Journal of physiology …, 2010 - jpp.krakow.pl
Amiodarone-induced pulmonary toxicity is a serious side-effect, but the underlying
molecular mechanisms remain unclear. We examined phospholipidosis and apoptosis in rat …

Accumulation of amiodarone and desethylamiodarone by rat alveolar macrophages in cell culture

JM Antonini, MJ Reasor - Biochemical pharmacology, 1991 - Elsevier
Amiodarone is a clinically effective antiarrhythmic drug shown to cause lung damage in
humans and animals. While the mechanism of this pulmonary toxicity is unknown, it may be …

Amiodarone increases the accumulation of DEA in a human alveolar epithelium-derived cell line

S Seki, S Itagaki, M Kobayashi, T Hirano… - Biological and …, 2008 - jstage.jst.go.jp
MATERIALS AND METHODS Chemicals AMD and DEA were kindly supplied by Taisho
Pharmaceutical (Tokyo, Japan). All other reagents were of the highest grade available and …